Transcatheter aortic and mitral valve interventions: update 2010

Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk

“…TAVI was performed in a standard manner as described previously. 12 Patients considered eligible for TAVI were generally older than 75 years of age although age alone did not qualify as a single criterion for TAVI. All patients were considered to be at high surgical risk owing to comorbidities with a logistic EuroSCORE of 20% or greater.…”

Impact of MitraClip™ therapy on secondary mitral valve surgery in patients at high surgical risk

“…Further, operative risk is elevated as compared with MVR for degenerative MR [4]. It is for this growing population of high-risk patients that less invasive treatment alternatives have been explored, leading to the development and clinical implementation of trans-catheter MVR devices [5]. The MitraClip TM device (Abbott Vascular, Menlo Park, CA, USA) aims to achieve a similar effect as surgical edge-to-edge repair in a beatingheart, catheter-based adaptation.…”